Document is current
Any future updates will be listed below
-
Authors
Lloyd-Price, Jason
Arze, Cesar
Ananthakrishnan, Ashwin N.
Schirmer, Melanie
Avila-Pacheco, Julian
Poon, Tiffany W.
Andrews, Elizabeth
Ajami, Nadim J.
Bonham, Kevin S.
Brislawn, Colin J.
Casero, David
Courtney, Holly
Gonzalez, Antonio
Graeber, Thomas G.
Hall, A. Brantley
Lake, Kathleen
Landers, Carol J.
Mallick, Himel
Plichta, Damian R.
Prasad, Mahadev
Rahnavard, Gholamali
Sauk, Jenny
Shungin, Dmitry
Vázquez-Baeza, Yoshiki
White, Richard A. III
,
Bishai, Jason
Bullock, Kevin
Deik, Amy
Dennis, Courtney
Kaplan, Jess L.
Khalili, Hamed
McIver, Lauren J.
Moran, Christopher J.
Nguyen, Long
Pierce, Kerry A.
Schwager, Randall
Sirota-Madi, Alexandra
Stevens, Betsy W.
Tan, William
ten Hoeve, Johanna J.
Weingart, George
Wilson, Robin G.
Yajnik, Vijay
Braun, Jonathan
Denson, Lee A.
Jansson, Janet K.
Knight, Rob
Kugathasan, Subra
McGovern, Dermot P. B.
Petrosino, Joseph F.
Stappenbeck, Thaddeus S.
Winter, Harland S.
Clish, Clary B.
Franzosa, Eric A.
Vlamakis, Hera
Xavier, Ramnik J.
Huttenhower, Curtis
- License Information
-
More Information
Article History
Received: 6 February 2018
Accepted: 16 April 2019
First Online: 29 May 2019
Competing interests
: J. Braun is on the Scientific Advisory Board for Janssen Research & Development, LLC. C.H. is on the Scientific Advisory Board for Seres Therapeutics. J.F.P. and N.J.A. own shares at Diversigen Inc. R.J.X. is a consultant to Novartis and Nestle.
